The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vor Biopharma Inc shares valued at $819,740 were sold by Reprogrammed Interchange LLC on Aug 25 ’25. At $2.12 per share, Reprogrammed Interchange LLC sold 387,346 shares. The insider’s holdings dropped to 38,586,755 shares worth approximately $77.56 million following the completion of this transaction.
Also, Reprogrammed Interchange LLC sold 284,190 shares, netting a total of over 591,343 in proceeds. Following the sale of shares at $2.08 each, the insider now holds 38,302,565 shares.
Before that, Robert Ang had added 18,382 shares to its account. In a trade valued at $36,407, the Officer bought Vor Biopharma Inc shares for $1.98 each.
As published in a research note from H.C. Wainwright on June 30, 2025, Vor Biopharma Inc [VOR] has been rated up from a Neutral to a Buy and the price target has been revised to $3. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in late July. As of April 27, 2022, Goldman has initiated its “Neutral” rating for VOR. Earlier on December 17, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for VOR stock.
Analyzing VOR Stock Performance
On last trading session, Vor Biopharma Inc [NASDAQ: VOR] rose 0.50% to $2.01. The stock’s lowest price that day was $1.94, but it reached a high of $2.08 in the same session. During the last five days, there has been a drop of approximately -7.37%. Over the course of the year, Vor Biopharma Inc shares have jumped approximately 107.22%. Shares of the company reached a 52-week high of $3.29 on 07/08/25 and a 52-week low of $0.13 on 05/09/25.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 1.94, which, if violated, would cause prices to drop to 1.87. In the upper region, resistance lies at 2.08. The next price resistance is at 2.15. RSI (Relative Strength Index) is 49.71 on the 14-day chart, showing neutral technical sentiment.
Is Vor Biopharma Inc subject to short interest?
Stocks of Vor Biopharma Inc saw a sharp rise in short interest on 2025-08-15 jumping by 4.03 million shares to 18.41 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 14.38 million shares. A jump of 21.89% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.1 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.1.
Which companies own the most shares of Vor Biopharma Inc (VOR)?
In terms of Vor Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 3 in the next 12 months, up nearly 50.0% from the previous closing price of $2.0. Analysts anticipate Vor Biopharma Inc stock to reach 3 by 2025, with the lowest price target being 3. In spite of this, 2 analysts ranked Vor Biopharma Inc stock as Buy at the end of 2025. On December 03, 2021, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $38.
